Form 4: Amneal Pharmaceuticals Executive Vice President Andrew Boyer Sells Shares
SEC Form 4 Filing
Executive Vice President Andrew Boyer of Amneal Pharmaceuticals sold a portion of his Class A Common Stock holdings on August 14 and 15, 2024.
Summary
- Andrew Boyer, Executive Vice President of Amneal Pharmaceuticals, sold shares of Class A Common Stock on August 14 and 15, 2024.
- On August 14, 2024, he sold 22,486 shares at a weighted average price of $7.81 per share.
- On August 15, 2024, he sold 40,225 shares at a weighted average price of $7.85 per share.
- Following these transactions, Boyer directly owns 256,670 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. It doesn't inherently convey positive or negative sentiment, but the market's reaction to the stock sale could vary.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. Investors often monitor these filings to gain insights into management's perspective on the company's stock and future prospects.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Andrew Boyer sold 22,486 shares of Class A Common Stock. |
| 08/15/2024 | Andrew Boyer sold 40,225 shares of Class A Common Stock. |
| 08/16/2024 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.